Retraction Retraction dated 2024-10-22
Click to view Retraction: https://doi.org/10.1038/s41375-024-02443-z
-
Authors
Jiang, H
Acharya, C
An, G
Zhong, M
Feng, X
Wang, L
Dasilva, N
Song, Z
Yang, G
Adrian, F
Qiu, L
Richardson, P
Munshi, N C
Tai, Y-T
Anderson, K C
- License Information
-
More Information
Article History
Received: 18 May 2015
Revised: 20 August 2015
Accepted: 21 August 2015
First Online: 4 September 2015
Change Date: 22 October 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1038/s41375-024-02443-z
Competing interests
: ZS, GY and FA are employees of Sanofi whose product was used in this research. Y-TT is a consultant for Onyx. PR serves on advisory boards to Millennium, Celgene, Novartis, Johnson & Johnson and Bristol-Myers Squibb. NCM serves on advisory boards to Millennium, Celgene and Novartis. KCA serves on advisory boards to Onyx, Celgene, Gilead, Bristol-Myers Squibb and Sanofi-Aventis and is a scientific founder of Acetylon and Oncopep. The remaining authors declare no competing financial interest.
